Lunai Bioworks, Inc. (NASDAQ: RENB) announced its board of directors approved a 10:1 reverse stock split of its common stock ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE